我院与四川省23家医院2013-2015年中药注射剂应用对比分析

Comparative Analysis of the Utilization of TCM Injections between Our Hospital and 23 Hospitals Sichuan Province during 2013-2015

目的:为临床合理使用中药注射剂提供参考。方法:对我院及四川省23家医院2013-2015年中药注射剂使用种类、销售金额、用药频度(DDDs)、日均费用(DDC)和排序比(B/A)等进行统计分析与比较。结果:我院2013-2015年中药注射剂的品种数由36种降至33种,在住院患者中的使用率均为60%左右,而DDDs、销售金额及占比均逐年上升。四川省23家医院连续3年居销售金额和DDDs首位的都是注射用血栓通;我院2013、2014年销售金额和DDDs居首位的均为注射用红花黄色素,2015年分别是丹红注射液和参麦注射液,均为活血祛瘀类心脑血管药物。四川省23家医院B/A接近1的药品有注射用血栓通、注射用灯盏花素、喜炎平注射液等;我院B/A接近1的药品品种数多于四川省整体水平。我院抗肿瘤辅助用药的DDC普遍高于心脑血管类中药注射剂,其中消癌平注射液的DDC高达1 328.12元、康莱特注射液为577.90元,但该类药物DDDs普遍较低。结论:我院中药注射剂的使用率较高,且呈上升趋势,销售金额与使用频次同步性较好,且价格适中、疗效确切的品种占有较大份额,与四川省中药注射剂使用总体情况基本一致,但应警惕中药注射剂的不良反应风险,做到安全有效、经济地用药。

OBJECTIVE： To provide reference of clinical rational use of TCM injections. METHODS ： The utilization of TCM injections in our hospital and 23 hospitals of Sichuan province during 2013-2015 were analyzed statistically in terms of species, consumption sum, DDDs, daily drug cost （DDC） and sorting ratio （B/A）, etc. RESULTS： During 2013-2015, the varieties of TCM injections used in our hospital decreased from 36 to 33; the utilization ratio of TCM injections in inpatients was about 60%, while DDDs, consumption sum and constituent ratio increased year by year. In 3 years, Xueshuantong for injection always took up the first place in the list of consumption sum and DDDs in 23 hospitals of Sichuan province; in our hospital, Carthamin yellow for injection took up the first place in the list of consumption sum and DDDs in 2013 and 2014, while Danhong injection and Shenmai injection occupied the first in 2015, respecitively; those were eardio-cere brovascular drugs for promoting blood circulation to remove blood stasis. TCM injections B/A of which were close to 1 in 23 hospitals of Sichuan province were Xueshuantong for injec- tion, Breviscapine for injection and Xiyanping injection, etc. The types of TCM injections B/A of which were close to 1 in our hospital were more than that of Sichuan province. DDC of anti-tumor adjuvant drugs in our hospital were usually higher than those of cardio-cerebrovascular TCM injection, among which DDC of Xiaoaiping reached 1 328.12 yuan and that of Kanglaite injection was 577.90 yuan; DDDs of those injection were usually in low level. CONCLUSIONS： The application ratio of TCM injections in our hospital was high and showed an upward trend, and sales and use presented a good synchronism. TCM injections with suitable price and definite efficacy take up a large share and the situation is consistent with Sichuan province. Great importance should be at- tached to ADR risk of TCM injection so as to promote safe, effective and economical ase of drugs.